Who we are
Blueprint Genetics is a genetic testing company focused on inherited diseases. With a patient-first mindset, we deliver high-quality genetic testing to the global clinical community across 14 medical specialties. Blueprint Genetics is based in Helsinki and Seattle, with a customer base spanning over 70 countries.
What we do
We provide high-quality genetic testing for a global clinical community. By combining a state-of-the-art laboratory process, the latest sequencing technology, AI empowered data-crunching tools and techniques, world-class professionals, and a holistic customer experience approach, we are bringing genetic knowledge to mainstream healthcare.
We provide clinicians and their patients with comprehensive and high-quality tools and resources for diagnosis of genetic conditions. In doing so, we provide possibilities for targeted treatment and individualized care for patients.
Are you the one?
Become part of something that makes a difference. Join our team and help us develop industry-changing solutions for the benefit of patients and families living with inherited diseases.
New research collaboration helps shorten the path to diagnosis for rare disease patients through analysis of biobank samples
Helsinki Biobank, Helsinki University Hospital (HUS) and its Rare Disease Center, and Blueprint Genetics announce promising results from the first phase of the Rare3K research initiative. The unique collaboration has pioneered new ways to find individuals in biobanks who may benefit from genetic testing to obtain an accurate diagnosis. Treatment…Read more
See all news
The 4th International Conference on Rare Disorders
Blueprint Genetics will be attending the International Conference on Rare Diseases in Vienna on December 7-8, 2022.
See all events